共 50 条
- [42] Radiotherapy with Durvalumab vs. Cetuximab in Patients with Locoregionally Advanced Head and Neck Cancer and a Contraindication to Cisplatin: Phase II Results of NRG-HN004 [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (05): : 1058 - 1058
- [47] Combined-modality therapy for locoregionally advanced head and neck cancer [J]. ONCOLOGY-NEW YORK, 1999, 13 (10): : 83 - 91
- [49] Simultaneous Integrated Boost Intensity Modulated Radiotherapy in the Inoperable Locoregionally Advanced Head and Neck Cancer: Clinical Results [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S475 - S475
- [50] CLINICAL PRACTICE GUIDANCE FOR RADIOTHERAPY PLANNING AFTER INDUCTION CHEMOTHERAPY IN LOCOREGIONALLY ADVANCED HEAD-AND-NECK CANCER [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : 725 - 733